MDM2 antagonist IV prevents the degradation of p53 by inhibiting the MDM2-p53 interaction, leading to increased p53 levels and promoting apoptosis in p53-responsive cells.
Molecular Weight
377.97
Molecular Formula
C15H12BIO3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
MDM2 antagonist IV can be used to explore the inhibition of MDM2 and reactivation of p53 in cancer therapy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.